<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34884216</PMID><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>23</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>25</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Dysautonomia and Implications for Anosmia in Long COVID-19 Disease.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5514</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm10235514</ELocationID><Abstract><AbstractText>Long COVID-19 patients often reported anosmia as one of the predominant persisting symptoms. Recent findings have shown that anosmia is associated with neurological dysregulations. However, the involvement of the autonomic nervous system (ANS), which can aggregate all the long COVID-19 neurological symptoms, including anosmia, has not received much attention in the literature. Dysautonomia is characterized by the failure of the activities of components in the ANS. Long COVID-19 anosmia fatigue could result from damage to olfactory sensory neurons, leading to an augmentation in the resistance to cerebrospinal fluid outflow by the cribriform plate, and further causing congestion of the glymphatic system with subsequent toxic build-up in the brain. Studies have shown that anosmia was an important neurologic symptom described in long COVID-19 in association with potential COVID-19 neurotropism. SARS-CoV-2 can either travel via peripheral blood vessels causing endothelial dysfunction, triggering coagulation cascade and multiple organ dysfunction, or reach the systemic circulation and take a different route to the blood-brain barrier, damaging the blood-brain barrier and leading to neuroinflammation and neuronal excitotoxicity. SARS-CoV-2 entry via the olfactory epithelium and the increase in the expression of TMPRSS2 with ACE2 facilitates SARS-CoV-2 neurotropism and then dysautonomia in long COVID-19 patients. Due to this effect, patients with anosmia persisting 3 months after COVID-19 diagnosis showed extensive destruction of the olfactory epithelium. Persistent anosmia observed among long COVID-19 patients may be involved by a cascade of effects generated by dysautonomia leading to ACE2 antibodies enhancing a persistent immune activation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vall&#xe9;e</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9158-4467</Identifier><AffiliationInfo><Affiliation>Department of Clinical Research and Innovation, Foch Hospital, 92150 Suresnes, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">anosmia</Keyword><Keyword MajorTopicYN="N">dysautonomia</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">neurotropism</Keyword></KeywordList><CoiStatement>The author declares no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>10</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34884216</ArticleId><ArticleId IdType="pmc">PMC8658706</ArticleId><ArticleId IdType="doi">10.3390/jcm10235514</ArticleId><ArticleId IdType="pii">jcm10235514</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M.J., Van Herck M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C., Houben-Wilke S., Burtin C., Posthuma R., Franssen F.M.E., et al. Persistent Symptoms 3&#x2005;Months after a SARS-CoV-2 Infection: The Post-COVID-19 Syndrome? ERJ Open Res. 2020;6 doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerkin R.C., Ohla K., Veldhuizen M.G., Joseph P.V., Kelly C.E., Bakke A.J., Steele K.E., Farruggia M.C., Pellegrino R., Pepino M.Y., et al. Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms. Chem. Senses. 2021;46:bjaa081. doi: 10.1093/chemse/bjaa081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjaa081</ArticleId><ArticleId IdType="pmc">PMC7799216</ArticleId><ArticleId IdType="pubmed">33367502</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomelli A., Pezzati L., Conti F., Bernacchia D., Siano M., Oreni L., Rusconi S., Gervasoni C., Ridolfo A.L., Rizzardini G., et al. Self-Reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-Sectional Study. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2020;71:889&#x2013;890. doi: 10.1093/cid/ciaa330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa330</ArticleId><ArticleId IdType="pmc">PMC7184514</ArticleId><ArticleId IdType="pubmed">32215618</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., De Siati D.R., Horoi M., Le Bon S.D., Rodriguez A., Dequanter D., Blecic S., El Afia F., Distinguin L., et al. Olfactory and Gustatory Dysfunctions as a Clinical Presentation of Mild-to-Moderate Forms of the Coronavirus Disease (COVID-19): A Multicenter European Study. Eur. Arch. Oto-Rhino-Laryngol. Off. J. Eur. Fed. Oto-Rhino-Laryngol. Soc. EUFOS Affil. Ger. Soc. Oto-Rhino-Laryngol. Head Neck Surg. 2020;277:2251&#x2013;2261. doi: 10.1007/s00405-020-05965-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta E.M., Batra A., Clark J.R., Shlobin N.A., Hoffman S.C., Orban Z.S., Koralnik I.J. Frequent Neurologic Manifestations and Encephalopathy-Associated Morbidity in COVID-19 Patients. Ann. Clin. Transl. Neurol. 2020;7:2221&#x2013;2230. doi: 10.1002/acn3.51210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51210</ArticleId><ArticleId IdType="pmc">PMC7664279</ArticleId><ArticleId IdType="pubmed">33016619</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., Horn C., Vanshylla K., Cristanziano V.D., Osebold L., et al. Post-COVID Syndrome in Non-Hospitalised Patients with COVID-19: A Longitudinal Prospective Cohort Study. Lancet Reg. Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Altundag A., Saatci O., Sanli D.E.T., Duz O.A., Sanli A.N., Olmuscelik O., Temirbekov D., Kandemirli S.G., Karaaltin A.B. The Temporal Course of COVID-19 Anosmia and Relation to Other Clinical Symptoms. Eur. Arch. Oto-Rhino-Laryngol. 2021;278:1891&#x2013;1897. doi: 10.1007/s00405-020-06496-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06496-5</ArticleId><ArticleId IdType="pmc">PMC7686554</ArticleId><ArticleId IdType="pubmed">33237475</ArticleId></ArticleIdList></Reference><Reference><Citation>Barizien N., Le Guen M., Russel S., Touche P., Huang F., Vall&#xe9;e A. Clinical Characterization of Dysautonomia in Long COVID-19 Patients. Sci. Rep. 2021;11:14042. doi: 10.1038/s41598-021-93546-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93546-5</ArticleId><ArticleId IdType="pmc">PMC8263555</ArticleId><ArticleId IdType="pubmed">34234251</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., et al. Persistent Neurologic Symptoms and Cognitive Dysfunction in Non-Hospitalized COVID-19 &#x201c;Long Haulers&#x201d;. Ann. Clin. Transl. Neurol. 2021;8:1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and Predictors of Long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalvan V., Lee J., Bueso T., De Toledo J., Rivas K. Neurological Manifestations of COVID-19 and Other Coronavirus Infections: A Systematic Review. Clin. Neurol. Neurosurg. 2020;194:105921. doi: 10.1016/j.clineuro.2020.105921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2020.105921</ArticleId><ArticleId IdType="pmc">PMC7227498</ArticleId><ArticleId IdType="pubmed">32422545</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann D.H., Tsukahara T., Weinreb C., Lipovsek M., Van den Berge K., Gong B., Chance R., Macaulay I.C., Chou H.-J., Fletcher R.B., et al. Non-Neuronal Expression of SARS-CoV-2 Entry Genes in the Olfactory System Suggests Mechanisms Underlying COVID-19-Associated Anosmia. Sci. Adv. 2020;6:eabc5801. doi: 10.1126/sciadv.abc5801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc5801</ArticleId><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Fodoulian L., Tuberosa J., Rossier D., Boillat M., Kan C., Pauli V., Egervari K., Lobrinus J.A., Landis B.N., Carleton A., et al. SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain. iScience. 2020;23:101839. doi: 10.1016/j.isci.2020.101839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101839</ArticleId><ArticleId IdType="pmc">PMC7685946</ArticleId><ArticleId IdType="pubmed">33251489</ArticleId></ArticleIdList></Reference><Reference><Citation>Eshak N., Abdelnabi M., Ball S., Elgwairi E., Creed K., Test V., Nugent K. Dysautonomia: An Overlooked Neurological Manifestation in a Critically Ill COVID-19 Patient. Am. J. Med. Sci. 2020;360:427&#x2013;429. doi: 10.1016/j.amjms.2020.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2020.07.022</ArticleId><ArticleId IdType="pmc">PMC7366085</ArticleId><ArticleId IdType="pubmed">32739039</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M., Dirksen A., Taraborrelli P., Torocastro M., Panagopoulos D., Sutton R., Lim P.B. Autonomic Dysfunction in &#x201c;Long COVID&#x201d;: Rationale, Physiology and Management Strategies. Clin. Med. Lond. Engl. 2020 doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Balcom E.F., Nath A., Power C. Acute and Chronic Neurological Disorders in COVID-19: Potential Mechanisms of Disease. Brain J. Neurol. 2021:awab302. doi: 10.1093/brain/awab302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab302</ArticleId><ArticleId IdType="pmc">PMC8719840</ArticleId><ArticleId IdType="pubmed">34398188</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H., Patcai J. Chronic Widespread Musculoskeletal Pain, Fatigue, Depression and Disordered Sleep in Chronic Post-SARS Syndrome; a Case-Controlled Study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Desforges M., Le Coupanec A., Stodola J.K., Meessen-Pinard M., Talbot P.J. Human Coronaviruses: Viral and Cellular Factors Involved in Neuroinvasiveness and Neuropathogenesis. Virus Res. 2014;194:145&#x2013;158. doi: 10.1016/j.virusres.2014.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.09.011</ArticleId><ArticleId IdType="pmc">PMC7114389</ArticleId><ArticleId IdType="pubmed">25281913</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam S.B., Willows S., Kulka M., Sandhu J.K. Severe Acute Respiratory Syndrome Coronavirus 2 May Be an Underappreciated Pathogen of the Central Nervous System. Eur. J. Neurol. 2020;27:2348&#x2013;2360. doi: 10.1111/ene.14442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14442</ArticleId><ArticleId IdType="pmc">PMC7405269</ArticleId><ArticleId IdType="pubmed">32668062</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet Lond. Engl. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Vabret N., Britton G.J., Gruber C., Hegde S., Kim J., Kuksin M., Levantovsky R., Malle L., Moreira A., Park M.D., et al. Immunology of COVID-19: Current State of the Science. Immunity. 2020;52:910&#x2013;941. doi: 10.1016/j.immuni.2020.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7200337</ArticleId><ArticleId IdType="pubmed">32505227</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair A.S., McAlpine L.S., Gardin T., Farhadian S., Kuruvilla D.E., Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol. 2020;77:1018&#x2013;1027. doi: 10.1001/jamaneurol.2020.2065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2065</ArticleId><ArticleId IdType="pmc">PMC7484225</ArticleId><ArticleId IdType="pubmed">32469387</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafarzadeh A., Chauhan P., Saha B., Jafarzadeh S., Nemati M. Contribution of Monocytes and Macrophages to the Local Tissue Inflammation and Cytokine Storm in COVID-19: Lessons from SARS and MERS, and Potential Therapeutic Interventions. Life Sci. 2020;257:118102. doi: 10.1016/j.lfs.2020.118102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118102</ArticleId><ArticleId IdType="pmc">PMC7367812</ArticleId><ArticleId IdType="pubmed">32687918</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniz-Mondolfi A., Bryce C., Grimes Z., Gordon R.E., Reidy J., Lednicky J., Sordillo E.M., Fowkes M. Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) J. Med. Virol. 2020;92:699&#x2013;702. doi: 10.1002/jmv.25915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25915</ArticleId><ArticleId IdType="pmc">PMC7264598</ArticleId><ArticleId IdType="pubmed">32314810</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan T.P., DeOre B.J., Baldwin-Leclair A., Bullock T.A., McGary H.M., Khan J.A., Razmpour R., Hale J.F., Galie P.A., Potula R., et al. The SARS-CoV-2 Spike Protein Alters Barrier Function in 2D Static and 3D Microfluidic in-Vitro Models of the Human Blood-Brain Barrier. Neurobiol. Dis. 2020;146:105131. doi: 10.1016/j.nbd.2020.105131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105131</ArticleId><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarty N., Senthilnathan T., Paiola S., Gyani P., Castillo Cario S., Urena E., Jeysankar A., Jeysankar P., Ignatius Irudayam J., Natesan Subramanian S., et al. Neurological Pathophysiology of SARS-CoV-2 and Pandemic Potential RNA Viruses: A Comparative Analysis. FEBS Lett. 2021 doi: 10.1002/1873-3468.14227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.14227</ArticleId><ArticleId IdType="pmc">PMC8652524</ArticleId><ArticleId IdType="pubmed">34757622</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R., von Bartheld C.S. Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection. Neurosci. Rev. J. Bring. Neurobiol. Neurol. Psychiatry. 2020 doi: 10.1177/1073858420956905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858420956905</ArticleId><ArticleId IdType="pmc">PMC7488171</ArticleId><ArticleId IdType="pubmed">32914699</ArticleId></ArticleIdList></Reference><Reference><Citation>Wostyn P. COVID-19 and Chronic Fatigue Syndrome: Is the Worst yet to Come? Med. Hypotheses. 2021;146:110469. doi: 10.1016/j.mehy.2020.110469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110469</ArticleId><ArticleId IdType="pmc">PMC7836544</ArticleId><ArticleId IdType="pubmed">33401106</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouga L. Encephalitic Syndrome and Anosmia in COVID-19: Do These Clinical Presentations Really Reflect SARS-CoV-2 Neurotropism? A Theory Based on the Review of 25 COVID-19 Cases. J. Med. Virol. 2021;93:550&#x2013;558. doi: 10.1002/jmv.26309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26309</ArticleId><ArticleId IdType="pmc">PMC7405279</ArticleId><ArticleId IdType="pubmed">32672843</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., Laue M., Schneider J., Br&#xfc;nink S., Greuel S., et al. Olfactory Transmucosal SARS-CoV-2 Invasion as a Port of Central Nervous System Entry in Individuals with COVID-19. Nat. Neurosci. 2021;24:168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Burki N.K., Lee L.-Y. Mechanisms of Dyspnea. Chest. 2010;138:1196&#x2013;1201. doi: 10.1378/chest.10-0534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.10-0534</ArticleId><ArticleId IdType="pmc">PMC2972628</ArticleId><ArticleId IdType="pubmed">21051395</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Duarte A., Norcliffe-Kaufmann L. Is &#x201c;happy Hypoxia&#x201d; in COVID-19 a Disorder of Autonomic Interoception? A Hypothesis. Clin. Auton. Res. Off. J. Clin. Auton. Res. Soc. 2020;30:331&#x2013;333. doi: 10.1007/s10286-020-00715-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-020-00715-z</ArticleId><ArticleId IdType="pmc">PMC7362604</ArticleId><ArticleId IdType="pubmed">32671502</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta K., Mohanty S.K., Mittal A., Kalra S., Kumar S., Mishra T., Ahuja J., Sengupta D., Ahuja G. The Cellular Basis of Loss of Smell in 2019-NCoV-Infected Individuals. Brief. Bioinform. 2021;22:873&#x2013;881. doi: 10.1093/bib/bbaa168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbaa168</ArticleId><ArticleId IdType="pmc">PMC7462334</ArticleId><ArticleId IdType="pubmed">32810867</ArticleId></ArticleIdList></Reference><Reference><Citation>Gourtsoyannis J. COVID-19: Possible Reasons for the Increased Prevalence of Olfactory and Gustatory Dysfunction Observed in European Studies. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2020:ciaa685. doi: 10.1093/cid/ciaa685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa685</ArticleId></ArticleIdList></Reference><Reference><Citation>Somekh I., Yakub Hanna H., Heller E., Bibi H., Somekh E. Age-Dependent Sensory Impairment in COVID-19 Infection and Its Correlation with ACE2 Expression. Pediatr. Infect. Dis. J. 2020;39:e270&#x2013;e272. doi: 10.1097/INF.0000000000002817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002817</ArticleId><ArticleId IdType="pubmed">32658093</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryche B., St Albin A., Murri S., Lac&#xf4;te S., Pulido C., Ar Gouilh M., Lesellier S., Servat A., Wasniewski M., Picard-Meyer E., et al. Massive Transient Damage of the Olfactory Epithelium Associated with Infection of Sustentacular Cells by SARS-CoV-2 in Golden Syrian Hamsters. Brain. Behav. Immun. 2020;89:579&#x2013;586. doi: 10.1016/j.bbi.2020.06.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.06.032</ArticleId><ArticleId IdType="pmc">PMC7332942</ArticleId><ArticleId IdType="pubmed">32629042</ArticleId></ArticleIdList></Reference><Reference><Citation>Eshraghi A.A., Mirsaeidi M., Davies C., Telischi F.F., Chaudhari N., Mittal R. Potential Mechanisms for COVID-19 Induced Anosmia and Dysgeusia. Front. Physiol. 2020;11:1039. doi: 10.3389/fphys.2020.01039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.01039</ArticleId><ArticleId IdType="pmc">PMC7526435</ArticleId><ArticleId IdType="pubmed">33041842</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagare A.P., Sweeney M.D., Makshanoff J., Zlokovic B.V. Shedding of Soluble Platelet-Derived Growth Factor Receptor-&#x3b2; from Human Brain Pericytes. Neurosci. Lett. 2015;607:97&#x2013;101. doi: 10.1016/j.neulet.2015.09.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2015.09.025</ArticleId><ArticleId IdType="pmc">PMC4631673</ArticleId><ArticleId IdType="pubmed">26407747</ArticleId></ArticleIdList></Reference><Reference><Citation>Miners J.S., Kehoe P.G., Love S., Zetterberg H., Blennow K. CSF Evidence of Pericyte Damage in Alzheimer&#x2019;s Disease Is Associated with Markers of Blood-Brain Barrier Dysfunction and Disease Pathology. Alzheimers Res. Ther. 2019;11:81. doi: 10.1186/s13195-019-0534-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-019-0534-8</ArticleId><ArticleId IdType="pmc">PMC6745071</ArticleId><ArticleId IdType="pubmed">31521199</ArticleId></ArticleIdList></Reference><Reference><Citation>Nation D.A., Sweeney M.D., Montagne A., Sagare A.P., D&#x2019;Orazio L.M., Pachicano M., Sepehrband F., Nelson A.R., Buennagel D.P., Harrington M.G., et al. Blood-Brain Barrier Breakdown Is an Early Biomarker of Human Cognitive Dysfunction. Nat. Med. 2019;25:270&#x2013;276. doi: 10.1038/s41591-018-0297-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0297-y</ArticleId><ArticleId IdType="pmc">PMC6367058</ArticleId><ArticleId IdType="pubmed">30643288</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindahl P., Johansson B.R., Lev&#xe9;en P., Betsholtz C. Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice. Science. 1997;277:242&#x2013;245. doi: 10.1126/science.277.5323.242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.277.5323.242</ArticleId><ArticleId IdType="pubmed">9211853</ArticleId></ArticleIdList></Reference><Reference><Citation>Ed&#xe9;n A., Simr&#xe9;n J., Price R.W., Zetterberg H., Gissl&#xe9;n M. Neurochemical Biomarkers to Study CNS Effects of COVID-19: A Narrative Review and Synthesis. J. Neurochem. 2021;159:61&#x2013;77. doi: 10.1111/jnc.15459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15459</ArticleId><ArticleId IdType="pmc">PMC8420435</ArticleId><ArticleId IdType="pubmed">34170549</ArticleId></ArticleIdList></Reference><Reference><Citation>Nataraj C., Oliverio M.I., Mannon R.B., Mannon P.J., Audoly L.P., Amuchastegui C.S., Ruiz P., Smithies O., Coffman T.M. Angiotensin II Regulates Cellular Immune Responses through a Calcineurin-Dependent Pathway. J. Clin. Invest. 1999;104:1693&#x2013;1701. doi: 10.1172/JCI7451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI7451</ArticleId><ArticleId IdType="pmc">PMC409880</ArticleId><ArticleId IdType="pubmed">10606623</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Ortega M., Lorenzo O., Suzuki Y., Rup&#xe9;rez M., Egido J. Proinflammatory Actions of Angiotensins. Curr. Opin. Nephrol. Hypertens. 2001;10:321&#x2013;329. doi: 10.1097/00041552-200105000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00041552-200105000-00005</ArticleId><ArticleId IdType="pubmed">11342793</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim&#xf5;es e Silva A.C., Silveira K.D., Ferreira A.J., Teixeira M.M. ACE2, Angiotensin-(1-7) and Mas Receptor Axis in Inflammation and Fibrosis. Br. J. Pharmacol. 2013;169:477&#x2013;492. doi: 10.1111/bph.12159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12159</ArticleId><ArticleId IdType="pmc">PMC3682698</ArticleId><ArticleId IdType="pubmed">23488800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., Huan Y., Yang P., Zhang Y., Deng W., et al. A Crucial Role of Angiotensin Converting Enzyme 2 (ACE2) in SARS Coronavirus-Induced Lung Injury. Nat. Med. 2005;11:875&#x2013;879. doi: 10.1038/nm1267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1267</ArticleId><ArticleId IdType="pmc">PMC7095783</ArticleId><ArticleId IdType="pubmed">16007097</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma S., Abbas M., Verma S., Khan F.H., Raza S.T., Siddiqi Z., Ahmad I., Mahdi F. Impact of I/D Polymorphism of Angiotensin-Converting Enzyme 1 (ACE1) Gene on the Severity of COVID-19 Patients. Infect. Genet. Evol. J. Mol. Epidemiol. Evol. Genet. Infect. Dis. 2021;91:104801. doi: 10.1016/j.meegid.2021.104801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2021.104801</ArticleId><ArticleId IdType="pmc">PMC7929788</ArticleId><ArticleId IdType="pubmed">33676010</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii H., Tsuji T., Yuba T., Tanaka S., Suga Y., Matsuyama A., Omura A., Shiotsu S., Takumi C., Ono S., et al. High Levels of Anti-SSA/Ro Antibodies in COVID-19 Patients with Severe Respiratory Failure: A Case-Based Review: High Levels of Anti-SSA/Ro Antibodies in COVID-19. Clin. Rheumatol. 2020;39:3171&#x2013;3175. doi: 10.1007/s10067-020-05359-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05359-y</ArticleId><ArticleId IdType="pmc">PMC7447083</ArticleId><ArticleId IdType="pubmed">32844364</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Cao W., Jiang W., Xiao M., Li Y., Tang N., Liu Z., Yan X., Zhao Y., Li T., et al. Profile of Natural Anticoagulant, Coagulant Factor and Anti-Phospholipid Antibody in Critically Ill COVID-19 Patients. J. Thromb. Thrombolysis. 2020;50:580&#x2013;586. doi: 10.1007/s11239-020-02182-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02182-9</ArticleId><ArticleId IdType="pmc">PMC7346854</ArticleId><ArticleId IdType="pubmed">32648093</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Rosen L.B., Zhang Q., Michailidis E., Hoffmann H.-H., Zhang Y., Dorgham K., Philippot Q., Rosain J., B&#xe9;ziat V., et al. Autoantibodies against Type I IFNs in Patients with Life-Threatening COVID-19. Science. 2020;370:eabd4585. doi: 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur J.M., Forrest J.C., Boehme K.W., Kennedy J.L., Owens S., Herzog C., Liu J., Harville T.O. Development of ACE2 Autoantibodies after SARS-CoV-2 Infection. PLoS ONE. 2021;16:e0257016. doi: 10.1371/journal.pone.0257016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257016</ArticleId><ArticleId IdType="pmc">PMC8415618</ArticleId><ArticleId IdType="pubmed">34478478</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel S.K., Juno J.A., Lee W.S., Wragg K.M., Hogarth P.M., Kent S.J., Burrell L.M. Plasma ACE2 Activity Is Persistently Elevated Following SARS-CoV-2 Infection: Implications for COVID-19 Pathogenesis and Consequences. Eur. Respir. J. 2021;57:2003730. doi: 10.1183/13993003.03730-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03730-2020</ArticleId><ArticleId IdType="pmc">PMC7830336</ArticleId><ArticleId IdType="pubmed">33479113</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. Diverse Functional Autoantibodies in Patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D., Wirtheim E., Vetter P., Kalil A.C., Bruchfeld J., Runold M., Guaraldi G., Mussini C., Gudiol C., Pujol M., et al. Long-Term Consequences of COVID-19: Research Needs. Lancet Infect. Dis. 2020;20:1115&#x2013;1117. doi: 10.1016/S1473-3099(20)30701-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30701-5</ArticleId><ArticleId IdType="pmc">PMC7462626</ArticleId><ArticleId IdType="pubmed">32888409</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., Lu P., Weizman O.-E., Liu F., Dai Y., et al. Neuroinvasion of SARS-CoV-2 in Human and Mouse Brain. J. Exp. Med. 2021;218:e20202135. doi: 10.1084/jem.20202135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami A., Kitsukawa T., Takagi S., Fujisawa H. Developmentally Regulated Expression of a Cell Surface Protein, Neuropilin, in the Mouse Nervous System. J. Neurobiol. 1996;29:1&#x2013;17. doi: 10.1002/(SICI)1097-4695(199601)29:1&lt;1::AID-NEU1&gt;3.0.CO;2-F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4695(199601)29:1&lt;1::AID-NEU1&gt;3.0.CO;2-F</ArticleId><ArticleId IdType="pubmed">8748368</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J., Kuivanen S., van der Meer F., Kallio K., Kaya T., Anastasina M., et al. Neuropilin-1 Facilitates SARS-CoV-2 Cell Entry and Infectivity. Science. 2020;370:856&#x2013;860. doi: 10.1126/science.abd2985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2985</ArticleId><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R., Harilal S., Sabitha M., Pappachan L.K., Roshni P.R., Mathew B. Current Perspective of COVID-19 on Neurology: A Mechanistic Insight. Comb. Chem. High Throughput Screen. 2021 doi: 10.2174/1386207324666210805121828.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1386207324666210805121828</ArticleId><ArticleId IdType="pubmed">34353250</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinska K., Jakubowska P., Von Bartheld C.S., Butowt R. Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age. ACS Chem. Neurosci. 2020;11:1555&#x2013;1562. doi: 10.1021/acschemneuro.0c00210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00210</ArticleId><ArticleId IdType="pmc">PMC7241737</ArticleId><ArticleId IdType="pubmed">32379417</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani A., M&#xfc;ller L., Ostermann P.N., Gabriel E., Abida-Islam P., M&#xfc;ller-Schiffmann A., Mariappan A., Goureau O., Gruell H., Walker A., et al. SARS-CoV-2 Targets Neurons of 3D Human Brain Organoids. EMBO J. 2020;39:e106230. doi: 10.15252/embj.2020106230.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106230</ArticleId><ArticleId IdType="pmc">PMC7560208</ArticleId><ArticleId IdType="pubmed">32876341</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Han Y., Nilsson-Payant B.E., Gupta V., Wang P., Duan X., Tang X., Zhu J., Zhao Z., Jaffr&#xe9; F., et al. A Human Pluripotent Stem Cell-Based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids. Cell Stem Cell. 2020;27:125&#x2013;136. doi: 10.1016/j.stem.2020.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.06.015</ArticleId><ArticleId IdType="pmc">PMC7303620</ArticleId><ArticleId IdType="pubmed">32579880</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini L., Albecka A., Mallery D.L., Kellner M.J., Paul D., Carter A.P., James L.C., Lancaster M.A. SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids. Cell Stem Cell. 2020;27:951&#x2013;961. doi: 10.1016/j.stem.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7553118</ArticleId><ArticleId IdType="pubmed">33113348</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly J.L., Simonetti B., Klein K., Chen K.-E., Williamson M.K., Ant&#xf3;n-Pl&#xe1;garo C., Shoemark D.K., Sim&#xf3;n-Gracia L., Bauer M., Hollandi R., et al. Neuropilin-1 Is a Host Factor for SARS-CoV-2 Infection. Science. 2020;370:861&#x2013;865. doi: 10.1126/science.abd3072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3072</ArticleId><ArticleId IdType="pmc">PMC7612957</ArticleId><ArticleId IdType="pubmed">33082294</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M., Shen W., Rowan N.R., Kulaga H., Hillel A., Ramanathan M., Lane A.P. Elevated ACE-2 Expression in the Olfactory Neuroepithelium: Implications for Anosmia and Upper Respiratory SARS-CoV-2 Entry and Replication. Eur. Respir. J. 2020;56:2001948. doi: 10.1183/13993003.01948-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01948-2020</ArticleId><ArticleId IdType="pmc">PMC7439429</ArticleId><ArticleId IdType="pubmed">32817004</ArticleId></ArticleIdList></Reference><Reference><Citation>He L., M&#xe4;e M.A., Muhl L., Sun Y., Pietil&#xe4; R., Nahar K., Li&#xe9;banas E.V., Fagerlund M.J., Oldner A., Liu J., et al. Pericyte-Specific Vascular Expression of SARS-CoV-2 Receptor ACE2&#x2014;Implications for Microvascular Inflammation and Hypercoagulopathy in COVID-19 patients. BioRxiv. 2020 doi: 10.1101/2020.05.11.088500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.11.088500</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecarpentier Y., Vall&#xe9;e A. The Key Role of the Level of ACE2 Gene Expression in SARS-CoV-2 Infection. Aging. 2021;13:14552&#x2013;14556. doi: 10.18632/aging.203181.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.203181</ArticleId><ArticleId IdType="pmc">PMC8221359</ArticleId><ArticleId IdType="pubmed">34115612</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltr&#xe1;n-Corbellini &#xc1;., Chico-Garc&#xed;a J.L., Mart&#xed;nez-Poles J., Rodr&#xed;guez-Jorge F., Natera-Villalba E., G&#xf3;mez-Corral J., G&#xf3;mez-L&#xf3;pez A., Monreal E., Parra-D&#xed;az P., Cort&#xe9;s-Cuevas J.L., et al. Acute-Onset Smell and Taste Disorders in the Context of COVID-19: A Pilot Multicentre Polymerase Chain Reaction Based Case-Control Study. Eur. J. Neurol. 2020;27:1738&#x2013;1741. doi: 10.1111/ene.14273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14273</ArticleId><ArticleId IdType="pmc">PMC7264557</ArticleId><ArticleId IdType="pubmed">32320508</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahra S.A., Iddawela S., Pillai K., Choudhury R.Y., Harky A. Can Symptoms of Anosmia and Dysgeusia Be Diagnostic for COVID-19? Brain Behav. 2020;10:e01839. doi: 10.1002/brb3.1839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1839</ArticleId><ArticleId IdType="pmc">PMC7667367</ArticleId><ArticleId IdType="pubmed">32935915</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas-Lechuga M.J., Izquierdo-Dom&#xed;nguez A., Chiesa-Estomba C., Calvo-Henr&#xed;quez C., Villarreal I.M., Cuesta-Chasco G., Bernal-Sprekelsen M., Mullol J., Alobid I. Chemosensory Dysfunction in COVID-19 out-Patients. Eur. Arch. Oto-Rhino-Laryngol. 2021;278:695&#x2013;702. doi: 10.1007/s00405-020-06266-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06266-3</ArticleId><ArticleId IdType="pmc">PMC7447084</ArticleId><ArticleId IdType="pubmed">32844305</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirschenbaum D., Imbach L.L., Ulrich S., Rushing E.J., Keller E., Reimann R.R., Frauenknecht K.B.M., Lichtblau M., Witt M., Hummel T., et al. Inflammatory Olfactory Neuropathy in Two Patients with COVID-19. Lancet Lond. Engl. 2020;396:166. doi: 10.1016/S0140-6736(20)31525-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31525-7</ArticleId><ArticleId IdType="pmc">PMC7351381</ArticleId><ArticleId IdType="pubmed">32659210</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Hopkins C., Sandison A., Manca A., Machouchas N., Turilli D., Lechien J.R., Barillari M.R., Salzano G., Cossu A., et al. Olfactory Epithelium Histopathological Findings in Long-Term Coronavirus Disease 2019 Related Anosmia. J. Laryngol. Otol. 2020;134:1123&#x2013;1127. doi: 10.1017/S0022215120002455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215120002455</ArticleId><ArticleId IdType="pmc">PMC7729153</ArticleId><ArticleId IdType="pubmed">33190655</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Benna S. Association of High Level Gene Expression of ACE2 in Adipose Tissue with Mortality of COVID-19 Infection in Obese Patients. Obes. Med. 2020;19:100283. doi: 10.1016/j.obmed.2020.100283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.obmed.2020.100283</ArticleId><ArticleId IdType="pmc">PMC7368415</ArticleId><ArticleId IdType="pubmed">32835126</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Heialy S., Hachim M.Y., Senok A., Gaudet M., Abou Tayoun A., Hamoudi R., Alsheikh-Ali A., Hamid Q. Regulation of Angiotensin- Converting Enzyme 2 in Obesity: Implications for COVID-19. Front. Physiol. 2020;11:555039. doi: 10.3389/fphys.2020.555039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.555039</ArticleId><ArticleId IdType="pmc">PMC7531362</ArticleId><ArticleId IdType="pubmed">33071815</ArticleId></ArticleIdList></Reference><Reference><Citation>Krams I.A., Luoto S., Rantala M.J., J&#xf5;ers P., Krama T. COVID-19: Fat, Obesity, Inflammation, Ethnicity, and Sex Differences. Pathog. Basel Switz. 2020;9:e887. doi: 10.3390/pathogens9110887.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens9110887</ArticleId><ArticleId IdType="pmc">PMC7692736</ArticleId><ArticleId IdType="pubmed">33114495</ArticleId></ArticleIdList></Reference><Reference><Citation>Krams I.A., J&#xf5;ers P., Luoto S., Trakimas G., Lietuvietis V., Krams R., Kaminska I., Rantala M.J., Krama T. The Obesity Paradox Predicts the Second Wave of COVID-19 to Be Severe in Western Countries. Int. J. Environ. Res. Public. Health. 2021;18:1029. doi: 10.3390/ijerph18031029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18031029</ArticleId><ArticleId IdType="pmc">PMC7908102</ArticleId><ArticleId IdType="pubmed">33503828</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>